Case guide

UPDATED FEB 2026

PowerPort Cardiac Perforation — Heart Surgery Risk

Part of the Bard PowerPort Catheter investigation

The short answer

Cardiac perforation by a fractured PowerPort catheter fragment is a life-threatening emergency. The thin-walled right ventricle is particularly vulnerable to penetration by a fragment's sharp edge, causing cardiac tamponade — a surgical emergency that can be fatal within minutes without treatment.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Cardiac Tamponade: A Surgical Emergency

Cardiac tamponade occurs when blood accumulates in the pericardial sac — the fibrous membrane encasing the heart — and compresses the heart chambers, preventing them from filling adequately with blood. Even a small volume of blood accumulating rapidly (50-100 mL) in the pericardial space can cause tamponade physiology because the pericardium is inelastic and cannot expand to accommodate the extra volume. As intrapericardial pressure rises, cardiac output falls, blood pressure drops, and the patient develops shock. Without emergency pericardiocentesis (needle drainage) or surgical pericardiotomy, tamponade progresses to cardiac arrest and death within minutes.

A fractured PowerPort catheter fragment lodged in the right ventricle can cause perforation by several mechanisms. The fragment may migrate slowly and penetrate the right ventricular free wall or apex. Rapid right ventricular contractions during exercise or tachycardia can drive the fragment tip into the myocardium. The fragment can also lacerate the wall during the snare retrieval procedure if not properly immobilized during retrieval. Cardiac perforation from a catheter fragment is a recognized, serious adverse event that has been reported to the FDA through the Medical Device Reporting system — reports that Bard and BD were obligated to review and respond to with appropriate product warnings or recalls.

Beck's Triad — Recognizing Tamponade

Emergency physicians and cardiologists recognize cardiac tamponade through a classic clinical triad: hypotension (low blood pressure), distended neck veins (jugular venous distension from backed-up venous pressure), and muffled heart sounds (dampened by pericardial fluid). In patients with a known PowerPort catheter fracture history, tamponade should be immediately suspected with any of these signs. Point-of-care ultrasound (POCUS) at the bedside can confirm pericardial effusion in minutes. Emergency pericardiocentesis, guided by ultrasound, can drain the compressing fluid and stabilize the patient pending surgical repair.

Surgical Repair and Long-Term Cardiac Consequences

Surgical repair of cardiac perforation from a catheter fragment requires open cardiac surgery, typically with cardiopulmonary bypass support. The surgeon removes the fragment, repairs the perforation site, evacuates the pericardial blood, and assesses for associated valve or conduction system damage. Post-operative recovery in the ICU is followed by a prolonged hospitalization. Long-term consequences include the sequelae of pericardial inflammation — constrictive pericarditis (scarring of the pericardium that restricts heart filling), pericardial adhesions, reduced cardiac function, and arrhythmia. Patients who survive cardiac perforation from a PowerPort fragment bear lifelong cardiovascular monitoring requirements and frequently report permanent changes in exercise capacity and quality of life.

Key data

Data & Statistics

3 SOURCED FIGURES

Cardiac tamponade mortality rate without emergency treatment: near 100% within minutes

ATLS / Emergency Cardiology Literature

Right ventricular free wall perforation requires open cardiac surgery in most cases

Journal of Thoracic and Cardiovascular Surgery

Post-tamponade constrictive pericarditis incidence: 1-2% after purulent pericarditis, higher after recurrent effusions

European Heart Journal, 2015

FAQ

Frequently Asked Questions

12 QUESTIONS

A Bard PowerPort is a brand of implantable venous access port (IVAP) made by C.R. Bard (now part of Becton Dickinson). It consists of a small reservoir implanted under the chest skin connected to a polyurethane catheter threaded into a large central vein near the heart. The device provides long-term intravenous access for chemotherapy, blood draws, and medication delivery without repeated needle sticks. Millions of patients have received PowerPort devices, with cancer patients being the primary recipients. The defect at the center of current litigation is the polyurethane catheter's susceptibility to fracturing inside the body over time.

Dive deeper

Related Guides

9 GUIDES

The full investigation

Part of the Bard PowerPort Catheter Investigation